Literature DB >> 23450374

Exploiting online discussions to discover unrecognized drug side effects.

H Wu1, H Fang, S J Stanhope.   

Abstract

BACKGROUND: Drugs can treat human diseases through chemical interactions between the ingredients and intended targets in the human body. However, the ingredients could unexpectedly interact with off-targets, which may cause adverse drug side effects. Notifying patients and physicians of potential drug effects is an important step in improving healthcare quality and delivery.
OBJECTIVE: With the increasing popularity of Web 2.0 applications, more and more patients start discussing drug side effects in many online sources. These online discussions form a valuable source for mining interesting knowledge about side effects. The main goal of this paper is to investigate the feasibility of exploiting these discussions to discover unrecognized drug side effects.
METHODS: We propose methods that can 1) build a knowledge base for drug side effects by automatically integrating the information related to drug side effects from different sources; and 2) monitor online discussions about drugs and discover potential unrecognized drug side effects.
RESULTS: Experiment results show that the online discussions indeed provide useful information discovering unrecognized drug side effects. We find that the integrated knowledge base contains more information than individual online sources. Moreover, both proposed detection methods can identify the side effects related to the four recently recalled drugs, and the information from online discussions makes it possible to make the detection much earlier than official announcements. Finally, the proposed generative modeling method is shown to be more effective than the discriminative method.
CONCLUSIONS: We find that it is possible to monitor online discussions to detect unrecognized drug side effects. The developed system is expected to serve as a complementary tool for drug companies and FDA to receive feedbacks from the patients, and it has the potentials to expedite the discovery process of unrecognized drug side effects and to improve the quality of healthcare.

Entities:  

Mesh:

Year:  2013        PMID: 23450374     DOI: 10.3414/ME12-02-0004

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  16 in total

1.  Social Media Listening for Routine Post-Marketing Safety Surveillance.

Authors:  Gregory E Powell; Harry A Seifert; Tjark Reblin; Phil J Burstein; James Blowers; J Alan Menius; Jeffery L Painter; Michele Thomas; Carrie E Pierce; Harold W Rodriguez; John S Brownstein; Clark C Freifeld; Heidi G Bell; Nabarun Dasgupta
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

2.  From bed to bench: bridging from informatics practice to theory: an exploratory analysis.

Authors:  R Haux; C U Lehmann
Journal:  Appl Clin Inform       Date:  2014-10-29       Impact factor: 2.342

3.  HARNESSING SOCIAL MEDIA FOR HEALTH INFORMATION MANAGEMENT.

Authors:  Lina Zhou; Dongsong Zhang; Chris Yang; Yu Wang
Journal:  Electron Commer Res Appl       Date:  2017-12-29       Impact factor: 6.014

Review 4.  Big data in medicine is driving big changes.

Authors:  F Martin-Sanchez; K Verspoor
Journal:  Yearb Med Inform       Date:  2014-08-15

Review 5.  Systematic review on the prevalence, frequency and comparative value of adverse events data in social media.

Authors:  Su Golder; Gill Norman; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2015-09-16       Impact factor: 4.335

6.  Empowerment of patients in online discussions about medicine use.

Authors:  Jasper J van Berkel; Mattijs S Lambooij; Ingrid Hegger
Journal:  BMC Med Inform Decis Mak       Date:  2015-04-08       Impact factor: 2.796

Review 7.  Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review.

Authors:  Jérémy Lardon; Redhouane Abdellaoui; Florelle Bellet; Hadyl Asfari; Julien Souvignet; Nathalie Texier; Marie-Christine Jaulent; Marie-Noëlle Beyens; Anita Burgun; Cédric Bousquet
Journal:  J Med Internet Res       Date:  2015-07-10       Impact factor: 5.428

8.  Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts.

Authors:  Carrie E Pierce; Khaled Bouri; Carol Pamer; Scott Proestel; Harold W Rodriguez; Hoa Van Le; Clark C Freifeld; John S Brownstein; Mark Walderhaug; I Ralph Edwards; Nabarun Dasgupta
Journal:  Drug Saf       Date:  2017-04       Impact factor: 5.606

Review 9.  Patient Participation and the Use of Ehealth Tools for Pharmacoviligance.

Authors:  Joëlle Berrewaerts; Laure Delbecque; Pierre Orban; Martin Desseilles
Journal:  Front Pharmacol       Date:  2016-04-11       Impact factor: 5.810

10.  Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions.

Authors:  Pierre Karapetiantz; Florelle Bellet; Bissan Audeh; Jérémy Lardon; Damien Leprovost; Rim Aboukhamis; François Morlane-Hondère; Cyril Grouin; Anita Burgun; Sandrine Katsahian; Marie-Christine Jaulent; Marie-Noëlle Beyens; Agnès Lillo-Le Louët; Cédric Bousquet
Journal:  Front Pharmacol       Date:  2018-05-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.